The study further demonstrated that the knockdown of ALKBH5 in GBMSCs reduced the expression of genes involved in GBM radioresistance and could inhibit the ability to repair DNA, leading to increased sensitivity to radiation therapy. Here, ALKBH5 is linked to glioblastoma.